Every material Form 8-K FMC filed with the SEC in 2025, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
On December 12, 2025, FMC's board approved Project Foundation, which includes exiting certain high-cost active ingredient and formulation plants and expects $175 million or more in annual run-rate savings by the end of 2027. The company expects pre-tax restructuring charges of approximately $560 to $635 million over the program's life, mostly non-cash write-offs, and separately warned of a significant non-cash goodwill and intangible impairment for 2025 unless its stock price recovers.
Project Foundation approved December 12, 2025, targeting $175 million or more in annual run-rate savings by the end of 2027.
Expected pre-tax restructuring charges of approximately $560 to $635 million, including $420 to $440 million in non-cash asset write-offs and/or accelerated depreciation.
Expected cash expenditures of $140 to $195 million, including $50 to $80 million in severance.
FMC expects a significant non-cash impairment of goodwill and intangibles in the 2025 financial statements absent a stock price recovery; the company says it will not affect cash flows.
FMC amended its credit agreement with Citibank as administrative agent, extending covenant relief on leverage and interest coverage ratios to the earlier of December 31, 2028 or a termination notice from the company. The amendment adds limits on subsidiary debt, dividend increases and intellectual property value, and requires a lien over substantially all assets if two rating agencies rate the company's public debt below the specified thresholds.
Amendment No. 5 dated December 8, 2025 extends covenant relief to the earlier of December 31, 2028 or a company termination notice
Subsidiary indebtedness is capped at $350 million outstanding principal during covenant relief, subject to exceptions
Regular quarterly dividend increases above $0.08 per share are limited, and other dividends are restricted unless leverage ratio is at or below 3.75 to 1
Company must keep qualifying intellectual property valued at no less than $1 billion; lien over substantially all assets applies if two agencies rate public debt below BB+ (S&P, Fitch) or Ba1 (Moody's)
FMC Corporation disclosed that director Anthony DiSilvestro resigned from its Board of Directors and all committees, effective immediately, on December 3, 2025. He cited increased professional commitments after being appointed Chief Financial Officer of Keurig Dr Pepper Inc. on November 25, 2025, along with scheduling conflicts with FMC board and committee meetings. The filing does not name a replacement, and the departure is a board change rather than a change in financial results or guidance.
Resignation from the FMC Board and all committees, effective immediately, notified December 3, 2025
Reason given: new role as CFO of Keurig Dr Pepper Inc., appointed November 25, 2025
Also cited: scheduling conflicts with FMC board and committee meeting dates
FMC thanked DiSilvestro for his service; the filing names no successor
FMC Corporation said on October 29, 2025 that President Ronaldo Pereira will step down effective December 15, 2025, by mutual agreement with Chairman and CEO Pierre Brondeau. Pereira will serve in an advisory capacity until that date to support the transition of his responsibilities.
Ronaldo Pereira's departure as President takes effect December 15, 2025
Pereira has been with FMC since 1995 and served as President since 2024
The decision was reached by mutual agreement with Pierre Brondeau, chairman and CEO
Pereira will be available in an advisory capacity until December 15, 2025
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every FMC filing is on SEC EDGAR ↗. 8-K briefs of other companies →